- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BTI gets $15 million equity investment
Magnetic source imaging developer Biomagnetic Technologies of San Diego received a $15 million capital infusion this month from the sale of stock to European investors. Some of the funds will be used to pay off $2 million in working capital loans from
Magnetic source imaging developer Biomagnetic Technologies of San Diego received a $15 million capital infusion this month from the sale of stock to European investors. Some of the funds will be used to pay off $2 million in working capital loans from Swiss shareholder Dassesta International, while the rest will be used to put the company on sounder financial footing as it seeks clinical acceptance for its Magnes 2500 Whole Head systems. BTI now has $13 million in cash, according to the company.
BTI also reported financial results for the second quarter (end-June), in which the firm dipped into the red on lower revenues. For the period, BTI had revenues of $616,000, compared with $5.3 million in the second quarter of 1997. The company's net loss was $1 million in the most recent period, compared with net income of $766,000 in the same period a year ago. BTI's backlog stands at $3.4
million.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
